March 9‒11, 2020
Sheraton Imperial Hotel Raleigh-Durham Airport
Research Triangle Park, N.C.
Early registration deadline is February 17, 2020.
Call for Papers deadline is January 13, 2020.
Development of parenteral formulations and processes is often multifaceted, as it has to address not only the characteristics of molecules but excipients, subsequent processing, and the primary container closure system. The degree of complexity increases if the product is intended to be filled into a syringe for lyophilization or used in a self-administration device. Throughout the development process, adequate characterization and controls are needed to assure both quality and sterility of the product is maintained and delivered to the patient.
With the recent excitement generated by gene, CAR-T, and other cell therapies, the use of sterile products has expanded and so have the difficulties in formulation, shipping, container closure integrity, and maintaining the viability of product at temperatures as low as -132°C.
The 2020 Arden House meeting will address current progress, lessons learned, and provide a forum for discussing new areas where there is a debate on the best approach to resolve the problem. Experts in the field of formulation, process, devices/combination products, aseptic risk assessment, and regulatory affairs will provide a unique learning forum for sharing experiences via case studies, practical examples, and success stories.
Learning Objectives
- Understand and provide practical solutions for the development of sterile drug products.
- Articulate the emerging areas of concerns (e.g., visual and subvisible particles, degradation of polysorbate), along with potential ways to address them.
- Recognize the regulatory expectations and good manufacturing requirements along with regional differences.
- Appreciate the complexity of container closure and device development, including integrity testing, extractables, and human-use studies.
- Become knowledgeable in formulation and process development with associated risks with aseptic processing, for example lyophilization, bioburden control, filtration,n and process simulation (media fill).
Register today!
Call for Papers
AAPS is now accepting poster abstract submissions related to the following topics for the 2020 Arden House conference:
- Analysis and Pharmaceutical Quality
- Biosimilars
- Biotechnology
- Chemistry, Manufacturing, and Controls (CMC)
- Formulation Design and Development
- Manufacturing Science and Engineering
- Patient-Centric Drug Development, Product Design, and Manufacturing
- Preformulation
- Process Development
- Protein Aggregation and Biological Consequences
- Protein Purification, Storage, and Transportation
- QbD and Product Performance
- Regulatory Sciences
- Stability
- Sterile Products
Poster presentation slots are limited to 40 and will be awarded on a first-submitted, first-accepted basis.
AAPS will close this Call for Papers on January 13 at 5:00 pm ET, or when the 40 slots have been awarded.
April 20‒22, 2020
Hilton McLean Tysons Corner
McLean, Va.
Early registration deadline is March 30, 2020.
Call for Papers deadline is February 26, 2020.
The 2020 AAPS Drug Transporters Workshop will be the 10th workshop in the long-standing series Drug Transporters in ADME: From the Bench to the Bedside. The overall goal of the workshop is to bring together world leaders in the transporter field from academia, industry, and regulatory agencies to enhance interaction and communication between these three entities.
Agenda Includes:
- Early Stage Investigator Presentations
- Humanized Transporter Animal Models
- Transporter Regulation
- Early Stage Investigator Presentations
- In Vitro to In Vivo Extrapolation
- Transporters as Drug Targets
- Transporters in Non-Traditional Barriers
- International Transporter Consortium
- Regulatory Perspectives
Register today!
Call for Papers
AAPS is now accepting abstract submissions for poster presentation at the Drug Transporters in ADME: From the Bench to the Bedside workshop. Poster presentation slots are limited to 40 and will be awarded on a first-submitted, first-accepted basis.
AAPS will close this Call for Papers on February 26 at 5:00 pm ET, or when the 40 slots have been awarded.
Partner with AAPS
Support AAPS’ Mission.
AAPS’ strategic partners, exhibiting partners, and conference sponsors play a vital role in pursuing AAPS’ mission to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health. With your support and involvement, AAPS will continue to help pharmaceutical scientists at every stage of drug development and delivery through our many educational programs, events, and communication initiatives.
Erik Burns, Ed.D., M.B.A., M.A. | +1.703.248.4738
PharmSci 360 2019 Conference Proceedings
AAPS members and event attendees will have exclusive access to the conference proceedings of the 2019 PharmSci 360 meeting. The proceedings include abstracts and posters displayed at the conference.
Workshop Thought Leadership and Sponsorship Opportunities
For workshop thought leadership and sponsorship opportunities, please view the workshop website. Or to discuss your organization’s unique needs, contact the Business Development Team directly:
Erik Burns, Ed.D., M.B.A., M.A. | +1.703.248.4738